{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:04:52Z","timestamp":1788321892112,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2019R1A6A1A03033084"],"award-info":[{"award-number":["2019R1A6A1A03033084"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.micpath.2019.103857","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T02:26:22Z","timestamp":1573007182000},"page":"103857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Enhancement of host infectivity, immunity, and protective efficacy by addition of sodium bicarbonate antacid to oral vaccine formulation of live attenuated Salmonella secreting Brucella antigens"],"prefix":"10.1016","volume":"138","author":[{"given":"Chamith","family":"Hewawaduge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Senevirathne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2019.103857_bib1","doi-asserted-by":"crossref","DOI":"10.3201\/eid0302.970219","article-title":"Brucellosis: an overview","author":"Corbel","year":"1997","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.micpath.2019.103857_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(06)70382-6","article-title":"The new global map of human brucellosis","author":"Pappas","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2019.103857_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001929","article-title":"Clinical manifestations of human brucellosis: a systematic review and meta-analysis","author":"Dean","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.micpath.2019.103857_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2017.05.012","article-title":"Brucella lipopolysaccharide reinforced Salmonella delivering Brucella immunogens protects mice against virulent challenge","author":"Lalsiamthara","year":"2017","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.micpath.2019.103857_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2018.e01079","article-title":"Development of new generation of vaccines for Brucella abortus","author":"Gheibi","year":"2018","journal-title":"Heliyon"},{"key":"10.1016\/j.micpath.2019.103857_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2009.07.001","article-title":"Brucella, an expanding der genus of zoonotic pathogens","author":"Whatmore","year":"2009","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.micpath.2019.103857_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/mi.2011.2","article-title":"Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agenda","author":"Griffin","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.micpath.2019.103857_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2016.02.014","article-title":"Mucosal vaccine delivery: current state and a pediatric perspective","author":"Shakya","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.micpath.2019.103857_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2016.1238536","article-title":"Presentation matters: buffers, packaging, and delivery devices for new, oral enteric vaccines for infants","author":"Lal","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2019.103857_bib10","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0703766104","article-title":"Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination","author":"Nochi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.micpath.2019.103857_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2017.04.008","article-title":"Current state and challenges in developing oral vaccines","author":"Vela Ramirez","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.micpath.2019.103857_bib12","article-title":"Novel adjuvants & delivery vehicles for vaccines development: a road ahead","author":"Mohan","year":"2013","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.micpath.2019.103857_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/iai.65.6.2107-2111.1997","article-title":"Comparison of alternative buffers for use with a new live oral cholera vaccine, Peru-15, in outpatient volunteers","author":"Sack","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2019.103857_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/iai.65.2.452-456.1997","article-title":"Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans","author":"Tacket","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2019.103857_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(86)91944-6","article-title":"{F}ield trial of oral cholera vaccines in {B}angladesh","author":"Clemens","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2019.103857_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/0264-410X(90)90012-B","article-title":"Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults","author":"Cryz","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2019.103857_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/159.4.766","article-title":"Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area","author":"Ferreccio","year":"1989","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2019.103857_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.70.7.3457-3467.2002","article-title":"Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers","author":"Hindle","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2019.103857_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.05153-11","article-title":"Dissimilar properties of two recombinant Lactobacillus acidophilus strains displaying Salmonella FliC with different anchoring motifs","author":"Kajikawa","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.micpath.2019.103857_bib20","doi-asserted-by":"crossref","DOI":"10.1097\/00004836-198604000-00008","article-title":"The effect of sodium bicarbonate versus aluminum\u2013magnesium hydroxide on postprandial gastric acid in duodenal ulcer patients","author":"Simmons","year":"1986","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.micpath.2019.103857_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087411","article-title":"A low gastric pH mouse model to evaluate live attenuated bacterial vaccines","author":"Brenneman","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2019.103857_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/jps.22284","article-title":"Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability","author":"Clapp","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.micpath.2019.103857_bib23","article-title":"Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids","author":"Lin","year":"1998","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.micpath.2019.103857_bib24","doi-asserted-by":"crossref","DOI":"10.4142\/jvs.2017.18.S1.281","article-title":"Development and trial of vaccines against Brucella","author":"Lalsiamthara","year":"2017","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.micpath.2019.103857_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00123-09","article-title":"Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection","author":"Pasquevich","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2019.103857_bib26","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1128\/IAI.72.4.2081-2087.2004","article-title":"Intraspleen delivery of A DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells","volume":"72","author":"Mu\u00f1oz-Montesino","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2019.103857_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016203","article-title":"An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice","volume":"6","author":"Pasquevich","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2019.103857_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.04.004","article-title":"Intermediate rough Brucella abortus S19\u03b4per mutant is DIVA enable, safe to pregnant Guinea pigs and confers protection to mice","author":"Lalsiamthara","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2019.103857_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/0264-410X(90)90247-J","article-title":"Brucella suis S2, Brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice","author":"Bosseray","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2019.103857_bib30","doi-asserted-by":"crossref","DOI":"10.1292\/jvms.11-0087","article-title":"Immune responses to new vaccine candidates constructed by a live attenuated Salmonella typhimurium delivery system expressing Escherichia coli F4, F5, F6, F41 and intimin adhesin antigens in a murine model","author":"HUR","year":"2011","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.micpath.2019.103857_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetimm.2019.02.001","article-title":"Attenuated Salmonella secreting Brucella protective antigens confer dual-faceted protection against brucellosis and salmonellosis in a mouse model","author":"Senevirathne","year":"2019","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.micpath.2019.103857_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2014.07.011","article-title":"Immunoprotection against influenza virus H9N2 by the oral administration of recombinant Lactobacillus plantarumNC8 expressing hemagglutinin in BALB\/c mice","author":"Shi","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.micpath.2019.103857_bib33","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2036.2002.01178.x","article-title":"Effects of antacid formulation on postprandial oesophageal acidity in patients with a history of episodic heartburn","author":"Robinson","year":"2002","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.micpath.2019.103857_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.71.2.690-696.2003","article-title":"Lon, a stress-induced ATP-dependent protease, is critically important for systemic Salmonella enterica serovar Typhimurium infection of mice","author":"Takaya","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2019.103857_bib35","article-title":"Immunogenicity of Ty21a attenuated \u201cSalmonella typhi\u201d given with sodium bicarbonate or in enteric-coated capsules","author":"Black","year":"1982","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.micpath.2019.103857_bib36","article-title":"A controlled field trial of live oral typhoid vaccine Ty21a","author":"Wahdan","year":"1980","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.micpath.2019.103857_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/S0378-1135(02)00255-9","article-title":"Brucellosis vaccines: past, present and future","author":"Schurig","year":"2002","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.micpath.2019.103857_bib38","doi-asserted-by":"crossref","DOI":"10.2460\/javma.2002.220.74","article-title":"Effect of an orally administered antacid agent containing aluminum hydroxide and magnesium hydroxide on abomasal luminal pH in clinically normal milk-fed calves","author":"Ahmed","year":"2002","journal-title":"J. Am. Vet. Med. Assoc."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240101931530X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240101931530X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:27:44Z","timestamp":1760110064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088240101931530X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":38,"alternative-id":["S088240101931530X"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2019.103857","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancement of host infectivity, immunity, and protective efficacy by addition of sodium bicarbonate antacid to oral vaccine formulation of live attenuated Salmonella secreting Brucella antigens","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2019.103857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103857"}}